Advertisement
Advertisement

FBIO

FBIO logo

Fortress Biotech, Inc.

2.39
USD
Sponsored
-0.01
-0.42%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

2.53

+0.14
+5.82%

Fortress Biotech, Inc. Profile

About

Fortress Biotech, Inc. is a biopharmaceutical company. The company is engaged in acquiring, developing and commercializing novel pharmaceutical and biotechnology products. Fortress Biotech, Inc., formerly known as Coronado Biosciences, Inc., is based in NEW YORK, United States.

Info & Links

CEO

Lindsay A. Rosenwald

Headquarters

1111 KANE CONCOURSE SUITE 301
BAY HARBOR ISLAND, FL 33154, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.fortressbiotech.com

Auditor

KPMG LLP

Share holders

389

Employees

78

Fortress Biotech, Inc. Statistics

Valuation Measures

Market Capitalization2

84.01M

Enterprise Value

57.05M

Enterprise Value/EBITDA(ttm)

-0.92

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

1.22

Price to Book(mrq)

1.20

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

67.47%

Operating Margin(ttm)

-32.11%

Profit Margin(ttm)

-14.60%

Return on Equity(ttm)

-41.20%

Return on Invested Capital(ttm)

-80.03%

Return on Assets(ttm)

-11.53%

Income Statement

Revenue(ttm)

63.26M

Revenue Per Share(ttm)

1.96

Gross Profit(ttm)

42.34M

EBITDA(ttm)3

-62.21M

Net Income Available to Common(ttm)

-1.88M

Diluted EPS(ttm)

-0.13

Share Statistics

Beta (5Y Monthly)

1.44

52-Week Change

41.42%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

32.20M

Dividend Yield

0.00%

Float4

23.22M

% Held by Insiders

27.90%

% Held by Institutions

96.51%

Balance Sheet

Total Cash(mrq)

79.38M

Total Cash Per Share(mrq)

2.47

Total Debt(mrq)

52.42M

Total Debt/Equity(mrq)

81.92%

Current Ratio(mrq)

2.19%

Quick Ratio(mrq)

2.30%

Book Value Per Share(mrq)

2.10

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.61

Free Cash Flow(ytd)

-52.07M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement